Newman’s Own, Inc. — Balsamic Vinaigrette
by Newman's Own, Inc.MRT 176 Panel Triggers Identified
Clinical Product Assessment
Newman’s Own, Inc. manufactures this product, which has been analyzed against the full MRT 176 panel — comprising 149 foods and 27 chemical additives — to identify potential immune-mediated sensitivities.
MRT Safety Assessment
This product contains 10 MRT-tested substances, including multiple vegetable oils, cane sugar, and several botanical aromatics. It is highly complex from an immunological standpoint, containing nightshade-family ingredients (red bell pepper and paprika) which map to chemical triggers Solanine and Capsaicin. Additionally, the inclusion of ‘spice’ introduces unknown variables that require further clarification. Given the high trigger count, this product is categorized as High Risk and is unsuitable for the initial elimination phases of the LEAP protocol.
Risk Summary
- Risk Classification: High Risk
- MRT Triggers Identified: 10
- Safe Ingredients: 4
- Unknown/Ambiguous: 1 (spice)
- LEAP Phase Compatibility: Phase 3 — Practitioner Guided
Flagged Ingredient Mapping
The following ingredients were identified as matching substances on the MRT 176 panel:
| Ingredient | Maps To (MRT Panel) | Match Type |
|---|---|---|
| canola oil | Canola/Rapeseed | Direct Match |
| soybean oil | Soybean | Direct Match |
| extra virgin olive oil | Olive | Direct Match |
| balsamic vinegar | Grape | Derived Match |
| sugar | Cane Sugar | Direct Match |
| garlic | Garlic | Direct Match |
| onion | Onion | Direct Match |
| red bell pepper | Solanine | Chemical Match |
| paprika | Paprika | Direct Match |
| paprika | Solanine | Chemical Match |
| paprika | Capsaicin | Chemical Match |
Unknown / Ambiguous Ingredients
The following ingredients could not be definitively mapped to the MRT 176 panel: spice. Patients should treat these as potential triggers until MRT testing confirms safety.
LEAP Protocol Guidance
With 10 MRT-tested substances identified, this product is not recommended during Phase 1 or Phase 2. Phase 3 (Maintenance) patients should consult their Certified LEAP Therapist.
UPC Code: 020662000057
Assessment Methodology
This assessment was generated using Wellbloom’s automated clinical analysis pipeline. Each ingredient was cross-referenced against the complete MRT 176 panel — including 149 food antigens and 27 chemical additives.
This is procedural data interpretation, not medical guidance. Always consult your Certified LEAP Therapist.
Understanding These Triggers
Canola oil (derived from rapeseed) is an MRT-tested substance. It is one of the most common cooking oils in processed foods and restaurant cooking. Look for it in fried foods, dressings, and baked goods.
Soy-derived ingredients appear in a wide range of processed foods including soy lecithin, soybean oil, and textured soy protein. One of the most prevalent hidden triggers.
Olive is tested on the MRT panel. Includes olive oil (one of the most common cooking oils), table olives, and olive-derived ingredients. A staple of Mediterranean diets.
Grape is an MRT-tested fruit found in wine, juice, jelly, raisins, and grape seed extract. Also a source of tartaric acid used as a food additive.
Cane sugar sensitivity is specific to sugarcane-derived sweeteners and is distinct from glucose intolerance. Look for it in ingredient lists as sucrose, cane juice, or turbinado sugar.
Garlic is an MRT-tested substance found in seasoning blends, sauces, and many processed foods. Often listed as "garlic powder," "dehydrated garlic," or hidden in "spices" or "natural flavors."
Onion is tested as a standalone substance on the MRT panel. It appears in seasonings, soups, sauces, and most savory processed foods. Often hidden as "dehydrated onion" or "onion powder" in spice blends.
Paprika is a dried Capsicum spice tested on the MRT panel. Used heavily in seasoning blends, sausages, cheese coatings, and snack foods. Often listed generically as "spices" on ingredient labels.
What This Means For Your Diet
With 10 identified triggers, this product has a high concentration of MRT-tested substances. The probability that at least one of these triggers is reactive on your personal panel is statistically significant.
This product is not recommended during Phase 1 (Elimination) or Phase 2 (Reintroduction). It may only be considered during Phase 3 (Maintenance) after your Certified LEAP Therapist has confirmed that all 10 substances scored Green on your individual MRT results.
Products with 3 or more MRT panel triggers require individualized evaluation. Do not attempt to self-assess — your CLT has the clinical training to weigh multiple reactive substances and potential cross-reactivity.
More from Newman's Own, Inc.
Find a LEAP Therapist
Get personalized guidance from a Certified LEAP Therapist in your area.
Browse Practitioners